Increased Inflammatory Response in Aged Mice
Is Associated With Age-related Zinc Deficiency
and Zinc Transporter Dysregulation

This section is compiled by Frank M. Painter, D.C.
Send all comments or additions to:

FROM: J Nutr Biochem. 2013 (Jan);   24 (1):   353–359 ~ FULL TEXT

Carmen P. Wong, Kathy R. Magnusson, and Emily Hoa

School of Biological and Population Health Sciences,
Oregon State University,
OR 97331, USA.

Aging is a complex process associated with physiological changes in numerous organ systems. In particular, aging of the immune system is characterized by progressive dysregulation of immune responses, resulting in increased susceptibility to infectious diseases, impaired vaccination efficacy and systemic low-grade chronic inflammation. Increasing evidence suggest that intracellular zinc homeostasis, regulated by zinc transporter expression, is critically involved in the signaling and activation of immune cells. We hypothesize that epigenetic alterations and nutritional deficits associated with aging may lead to zinc transporter dysregulation, resulting in decreases in cellular zinc levels and enhanced inflammation with age. The goal of this study was to examine the contribution of age-related zinc deficiency and zinc transporter dysregulation on the inflammatory response in immune cells. The effects of zinc deficiency and age on the induction of inflammatory responses were determined using an in vitro cell culture system and an aged mouse model. We showed that zinc deficiency, particularly the reduction in intracellular zinc in immune cells, was associated with increased inflammation with age. Furthermore, reduced Zip 6 expression enhanced proinflammatory response, and age-specific Zip 6 dysregulation correlated with an increase in Zip 6 promoter methylation. Furthermore, restoring zinc status via dietary supplementation reduced aged-associated inflammation. Our data suggested that age-related epigenetic dysregulation in zinc transporter expression may influence cellular zinc levels and contribute to increased susceptibility to inflammation with age.

From the FULL TEXT Article


Aging of the immune system results in a progressive dysregulation of immune responses including immunosenescence, where there is a gradual decline in both cellular and humoral immune responses, and increased susceptibility to infectious diseases and compromised vaccination efficacy in the elderly [1]. At the same time, “inflammaging,” a low-grade systemic chronic inflammation characterized by constitutively elevated levels of proinflammatory cytokines in blood, is commonly observed in the elderly population [2, 3]. Chronic inflammation has been implicated in the promotion of many age-related diseases including cancer, cardiovascular disease and autoimmune diseases. In addition, increases in inflammatory mediators in the blood are significant predictors of morbidity and mortality in aged individuals [4–6].

Zinc is an essential micronutrient required for many cellular processes, especially for the normal development and function of the immune system [7–9]. National surveys indicate that a significant portion of the aged population has inadequate zinc intake [10–13], and a decline in zinc status, as shown by plasma zinc concentrations, is observed with increasing age [14–17]. There are remarkable similarities between the hallmarks of zinc deficiency and age-related immunological dysfunction, both characterized by impaired immune responses and systemic chronic inflammation. Thus age-related zinc deficiency may play a significant role in age-associated dysregulation of immune function and may be a contributing factor in age-related inflammation and associated morbidities [18, 19]. Importantly, zinc has anti-inflammatory properties and low zinc status is associated with increased susceptibility to infections and exaggerated inflammatory responses [20–23]. Recent studies indicate that intracellular zinc homeostasis is critically involved in the signaling events in immune cells, and the regulation of cellular zinc in these immune cells is mediated by changes in the expression of specific zinc transporters [24–26]. Zinc transporters comprises a family of multiple transmembrane spanning domain proteins that are encoded by two solute-linked carrier (SLC) gene families: SLC30 (ZnT) and SLC39 (Zip) [27, 28]. ZnT and Zip family zinc transporters have opposing roles in regulating cellular zinc homeostasis; ZnT transporters reduce cytosolic zinc bioavailability by promoting zinc efflux and Zip transporters function by increasing cytosolic zinc. In the context of inflammation, stimulation of immune cells with inflammatory stimuli such as lipopolysaccharide (LPS) results in changes in cellular zinc that is mediated by alterations in zinc transporter expression [29]. Thus alterations and/or dysregulation of zinc transporter expression with age could potentially affect zinc homeostasis in immune cells and contribute to immune dysfunction and chronic inflammation [18, 30].

The mechanisms contributing to age-related zinc loss and age-related inflammation are unclear. Accumulating evidence indicates that epigenetic dysregulation is a common feature of aging, characterized by global DNA hypomethylation and gene-specific promoter hypermethylation or hypomethylation, as well as alteration in histone modifications [31–34]. In the immune system, age-associated epigenetic modifications such as DNA methylation have been shown to affect immune cell activation and may also contribute to the decline of cellular zinc with age, as several zinc transporters have been shown to be susceptible to epigenetic regulation [35–38]. At the same time, nutrient deficits such as zinc deficiency may further modulate epigenetic regulation [39–41]. The goal of the current study was to examine the contribution of age-related zinc deficiency and zinc transporter dysregulation on the inflammatory response in immune cells using an in vitro cell culture system and an aged mouse model. We hypothesized that age-related decreases in cellular zinc levels, in part, are mediated by epigenetic alterations that result in zinc transporter dysregulation and contribute to enhanced inflammation with age. Moreover, enhancing zinc status in aged mice should mitigate age-related inflammation.

Materials and methods

      Cell culture, in vitro zinc depletion and LPS treatments

Human monocytic cell line THP-1 was obtained from American Type Tissue Collection (Manassas, VA, USA). Cells were grown in RPMI 1640 culture medium with 10% fetal bovine serum (FBS) and maintained in humidified incubators with 5% CO2 at 37°C. Zinc-deficient (ZD) media were prepared, as previous published, using a chelation strategy in which zinc was removed from FBS by incubating with 10% Chelex 100 (wt/vol) (Sigma, St. Louis, MO, USA) overnight at 4°C with constant stirring. [42] THP-1 cells were cultured in zinc-adequate (ZA) medium (RPMI with 10% Chelex-treated FBS and 4 µM ZnCl2) or ZD medium (RPMI with 10% Chelex-treated FBS) for up to 14 days, and media were changed every 3 to 4 days. Mineral levels in tissue culture media and THP-1 cells were determined by inductively coupled plasma-optical emission spectroscopy (ICP-OES) and/or FluoZin-3 flow cytometry where appropriate. ZA or ZD THP-1 cells were treated with phorbol 12-myristate 13-acetate at 5 ng/ml for 48 h to induce the cells to differentiate into macrophages. Differentiated THP-1 macrophages were treated with 0, 10 or 100 ng/ml LPS (Sigma) for 6 h and harvested for zinc and gene expression analyses. Previous time-course studies indicated that LPS induced a rapid proinflammatory response (data not shown), and the 6-h time point was chosen to reflect optimal induction time for various genes of interest.

      Animals, diets and study design

Female C57Bl/6 mice at various ages (2–26 months) were purchased from the aged rodent colonies at the National Institute on Aging (Bethesda, MD, USA). Mice were housed in a temperature- and humidity-controlled environment and were fed standard rodent diet where appropriate, or randomly assigned to a purified ZA diet containing 30 mg/kg zinc, or a zinc-supplemented (ZS) diet containing 300 mg/kg zinc that was previously shown to be well tolerated and were able to normalize plasma zinc levels in old mice to levels similar to that of young mice. [43, 44] Purified ZA and ZS diets were purchased from Research Diets (New Brunswick, NJ, USA). Mice were fed ZA or ZS diets for 3 weeks. Food and water were provided ad libitum. Dietary intakes and body weights of all mice were monitored throughout the entire study. Mice were euthanized by CO2 asphyxiation at the termination of the experiments, and sera and tissues were collected. The animal protocol was approved by the Oregon State University Institutional Laboratory Animal Care and Use Committee. Tissues were processed immediately for ex vivo stimulation and/or differentiation or were preserved in RNALater (Life Technologies, Grand Island, NY, USA) for DNA and RNA isolation.

      Ex vivo differentiation of bone marrow-derived dendritic cells and macrophages

Bone marrow (BM)-derived dendritic cells (BMDCs) and macrophages (BMM) were differentiated ex vivo according to published protocols. [45, 46] BM cells were flushed and collected from the femurs and tibias of young and old mice. Red blood cells (RBCs) were removed using RBC lysis buffer (0.15 M NH4Cl, 1 mM KHCO3, 0.1 mM EDTA). BMs were adjusted to 1.5×106 cells/ml in RPMI media containing 10% FBS. BMDC and BMM were differentiated in media containing 20 ng/ml granulocyte/macrophage colony stimulating factor (GM-CSF) and 20 ng/ml macrophage colony stimulating factor (M-CSF), respectively (Peprotech, Rocky Hill, NJ, USA). Nonadherent cells were removed on days 2 and 4, and BMDC and BMM cells were harvested on day 7 for intracellular zinc analysis and siRNA transfections, respectively.

      Inflammatory response assays

For ex vivo splenocyte stimulation, spleens collected from young and old mice were made into single-cell suspension, and RBCs were removed using RBC lysis buffer. To determine how age and zinc status affect inflammatory response on a per cell basis, an equal number of splenocytes from young or old mice were seeded at 5×106 cells per well in 24-well culture plates and treated with 0, 0.1 and 1 µg/ml LPS for 6 h and harvested for zinc and gene expression analyses. Serum interleukin (IL)-6 levels were detected using mouse IL6 Ready-SET-Go ELISA kit from eBioscience (San Diego, CA, USA).

      Total and intracellular zinc measurements

Total zinc concentrations were determined using ICP-OES, as previously described, with minor modification. [47] Briefly, samples (plasma or cell pellets) were digested in 1 ml 70% ultrapure nitric acid and incubated overnight. Incubated samples were diluted with chelex-treated nanopure water to a final concentration of 7% nitric acid, centrifuged and analyzed using the Prodigy High Dispersion ICP-OES instrument (Teledyne Leeman Labs, Hudson, NH, USA) against known standards. Intracellular zinc levels were determined using FluoZin-3 acetoxymethyl ester (FluoZin-3), a cell permeable, zinc-specific fluorescent indicator that measures intracellular free zinc (Molecular Probes, Eugene, OR, USA), according to published methods. [48] Cells were labeled with 1 µM FluoZin-3 for 30 minutes at 37°C and washed once in phosphate-buffered saline. Intracellular zinc levels, as determined by FluoZin-3 mean fluorescence intensity, were analyzed by flow cytometry. Data were acquired using FACSCalibur (BD Biosciences, San Jose, CA, USA). Data analyses were performed using Summit software (DakoCytomation, Fort Collins, CO, USA).

      Proinflammatory and zinc transporter gene expression

Total RNA from tissues and treated cells were isolated using TRIzol (Invitrogen). Total RNA was reverse transcribed into cDNA using SuperScript III First-Strand Synthesis SuperMix for quantitative real-time polymerase chain reaction (qRT-PCR) (Invitrogen). Real-time PCR was performed using the following PCR primers: human tumor necrosis factor α (TNF) (forward: 5'-CCCCAGGGACCTCTCTCTAATC-3', reverse: 5'-GGTTTGCTACAACATGGGCTACA-3'), human IL1β (forward: 5'-CCTGTCCTGCGTGTTGAAAGA-3', reverse: 5'-GGGAACTGGGCAGACTCAAA-3'), human GAPDH (forward: 5'-CGAGATCCCTC-CAAAATCAA-3', reverse: 5'-TTCACACCCATGACGAACAT-3'), mouse TNFα (forward: 5'-CTGTAGCCCACGTCGTAGCA-3', reverse: 5'-GTGTGGGTGAGGAGCACGTA-3'), mouse IL1β (forward: 5'-AAGATGAAGGGCTGCTTCCAA-3', reverse: 5'-TGAAGGAAAAGAAGGTGCTCATG-3'), mouse Zip 6 (forward: 5'-AAGTGAGAAGAAGGCAGAAATCC-3', reverse: 5'-GGAGAAGATGTAACAGAGCATCG-3'), mouse ZnT 1 (forward: 5'-TGGATGTACAAG-TAAATGGGAATCT-3', reverse: 5'-GTCTTCAGTACAACCCTTCCAGTTA-3'), or mouse 18S ribosomal RNA (18S) (forward: 5'-CCGCAGCTAGGAATAATGGAAT-3', reverse: 5'-CGAACCTCCGACTTTCGTTCT-3'). Real-time PCR reactions were performed using Fast SYBR Green Mastermix (Invitrogen) on 7900HT Fast Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). Gene copies were determined using the standard curve method. A standard curvewas generated from serial dilutions of purified plasmid DNA that encoded for each gene of interest. Data represent the copy number of the gene of interest normalized to the copy number of GAPDH (for human) or 18S (for mouse) housekeeping genes.

      Zip 6 gene silencing

BM macrophages were harvested and transfected with Zip 6-specific siRNA (Ambion Silencer siRNA S98750) using siPORT Amine and Ambion Silencer siRNA Transfection kit (Applied Biosystems). Control cells were transfected with scrambled siRNA (Ambion Silencer Select Negative Control No. 1). Transfected cells were seeded in 24-well tissue culture plates at 3×105 cells per well for 24 h and treated with 0, 10 and 100 ng/ml LPS for 6 h and harvested for gene expression analyses.

      Genomic DNA isolation and DNA methylation analyses

Genomic DNA was isolated using DNeasy Blood and Tissue kit (Qiagen, Valencia, CA, USA). Global DNA methylation was measured using SuperSense Methylated DNA Quantification Kit (Epigentek, Brooklyn, NY, USA) and was reported as relative fluorescence units (RFUs) per 100 ng genomic DNA. Zip 6 promoter methylation was determined using Zip 6-specific EpiTect Methyl Profiler qPCR assay (Qiagen), which analyzed DNA methylation status of the CpG island within the Zip 6 promoter (Chr18 24761649–24762812).

      Statistical analyses

Statistical analyses were performed using GraphPad Prism Version 5.02 (Graph-Pad, La Jolla, CA, USA). All data were reported as mean±S.E.M. P values were determined using unpaired t test, one-way analysis of variance (ANOVA) or two-way ANOVA, where appropriate. Bonferroni post hoc tests were performed to determine differences among the means when there was a significant main effect in one-way or two-way ANOVA. Statistical significance was defined as P≤.05.


      Proinflammatory response is associated with reduced intracellular zinc
      and is enhanced by zinc deficiency

Figure 1

The effects of zinc deficiency on inflammation were determined in THP-1 cells in vitro. After 10 days of culture in ZD media, THP-1 cells had significantly lower total zinc compared to cells cultured in ZA media (Fig. 1A). In addition, stimulation of THP-1 cells with LPS (Toll-like receptor 4 agonist) significantly reduced intracellular zinc levels in ZA THP1 cells (Fig 1B). The intracellular zinc levels in ZD THP-1 cells remained significantly lower compared to ZA cells, both pre- and post-LPS stimulation (Fig. 1B). Zinc deficiency also enhanced the LPS-induced proinflammatory response. Stimulation of THP-1 cells with LPS elicited a well-characterized and dose-dependent proinflammatory response, as determined by the induction of two prototypical proinflammatory cytokines, TNFα and IL1β. Our data indicated that zinc deficiency significantly increased the expression of both TNFα (Fig. 1C) and IL1β (Fig. 1D) mRNA expression in ZD THP-1 cells compared to ZA THP-1 cells.

      Age-related reduction in intracellular zinc in immune cells is
      associated with enhanced proinflammatory response

Figure 2

Aging was associated with a decline in plasma zinc concentrations (Fig. 2A). Despite a reduction in plasma zinc, total tissue zinc levels (including brain, liver, pancreas and spleen) measured by ICP-OES were not significantly different between young and old mice (data not shown). However, although total zinc levels did not differ in several tissues, FluoZin-3 analysis revealed that intracellular zinc levels were significantly lower in immune organs including thymocytes, splenocytes and BM cells of aged mice (Fig. 2B). Notably, BMDCs of aged mice had lower intracellular zinc compared to BMDC from young mice, despite ex vivo differentiation and culture in ZA media. Importantly, our data suggested that age-related decreases in intracellular zinc in immune cells were associated with increasing inflammation, as was demonstrated by a significant increase in baseline IL1β mRNA expression in the spleens in aged mice (24 months) compared to young mice (3 months) (Fig. 2C). There was also a significant age effect where aged splenocytes exhibited an increase in induced IL1β mRNA expression compared to young splenocytes, when stimulated with LPS ex vivo (Fig 2D).

      Age-related increase in proinflammatory response is associated
      with dysregulation of Zip 6 zinc transporter expression

Figure 3

The regulation of cellular zinc homeostasis and immune activation is, in part, controlled by differential zinc transporter expression. [25, 29] There were no significant age-related changes in the baseline expression of zinc transporters (Zip 1–6, ZnT 1–7) in the spleens between young and aged mice (data not shown). In contrast, ex vivo LPS stimulation induced a significant up-regulation of Zip 6 expression in the splenocytes of the younger mice (3 and 12 months). This induction was blunted in the splenocytes of older mice (18 and 24 months; Fig. 3A). While the gene expression of other zinc transporters has also been reported to alter during LPS treatment [29], only Zip 6 had age-associated alteration in gene expression in response to LPS treatment. We next examined whether Zip 6 dysregulation in aged mice was associated with age-related epigenetic alterations, particularly with respect to changes in DNA methylation. Global DNA methylation was significantly decreased with age (Fig. 3B). However, a significant age-specific increase in DNA methylation within the CpG island in the Zip6 promoter region was observed (Fig. 3C). To demonstrate that Zip 6 was involved in the induction of a proinflammatory response, Zip 6 expression was silenced in BMMs prior to the induction of a LPS-mediated proinflammatory response. Zip 6 expression in BMM transfected with Zip 6 siRNA was significantly reduced compared to control. Further, gene silencing was specific to Zip 6, as ZnT 1 expression was unaffected (Fig. 3D). Upon LPS stimulation, Zip 6-silenced BMM had significantly increased TNFα expression compared to control (Fig. 3E). Taken together, our data suggested that Zip 6 dysregulation was involved in enhanced inflammation during aging.

      Dietary zinc supplementation decreases age-associated inflammation

Figure 4

We had previously shown that dietary zinc supplementation can improve the zinc status in aged mice. [44] In this study, we found that dietary zinc supplementation for 3 weeks also mitigated aged-related increases in proinflammatory cytokine levels. Age-related increases in serum IL6 were significantly reduced in aged mice fed a ZS diet compared to aged mice fed a ZA diet (Fig. 4A). Similarly, age-related increases in TNFα expression were significantly reduced in the splenocytes of aged mice fed a ZS diet (Fig. 4B). Our data indicated that restoring zinc status in aged mice could overcome and decrease chronic inflammation in old age.


Declining zinc status during aging may contribute to immune dysfunction and chronic inflammation, and many age-related health problems are conditions that are also associated with poor zinc status [30, 49]. While zinc is known to act as an anti-inflammatory agent, however to date, the precise mechanisms linking zinc, age and inflammation are unclear. Our study is the first to report the potential role of age-related epigenetic control on zinc homeostasis. Specifically, these studies provide new evidence that suggests that methylation of specific zinc transporters with age may be one of the contributing factors resulting in zinc transporter dysregulation, and age-related zinc deficiency and inflammation. In this study, we demonstrated that zinc deficiency, particularly the reduction in intracellular zinc within immune cells, was associated with increased inflammation with increased age of the animal. We further showed that reduced Zip 6 mRNA expression enhanced proinflammatory responses, and age-specific Zip 6 dysregulation correlated with an increase in Zip 6 promoter methylation. Moreover, restoring zinc status via dietary supplementation reduced aged-associated inflammation. Our animal data suggested that age-related epigenetic dysregulation in zinc transporter expression may influence cellular zinc levels and contribute to increased susceptibility to inflammation with age.

Recent studies indicate that intracellular zinc homeostasis is critically involved in the signaling events in immune cells [24]. For example, T-cell receptor signaling and Th1 cell differentiation are controlled by activation-induced zinc influx during T-cell activation, and in DC, a reduction in intracellular zinc is required for DC maturation and antigen presentation [25, 29, 50]. In our in vitro study, LPS-stimulated proinflammatory response was accompanied by a significant reduction in intracellular zinc in THP-1 macrophages (Fig. 1). We further showed that reduced intracellular zinc in immune cells of aged mice was associated with increased inflammatory response (Fig. 2). Our data suggested that a decrease in cellular zinc was required for the induction of a proinflammatory response that was dysregulated with age and reaffirmed the importance of zinc homeostasis in controlling immune cell activation.

Zinc transporters play an important role in regulating cellular zinc homeostasis. Members of Zip and ZnT zinc transporter families exhibit tissue and cell-specific expression and possess differential responsiveness to dietary zinc, as well as to physiologic stimuli, including cytokines [27, 51]. The expression of zinc transporters has been profiled in immune cell types, and their regulation plays an important role in specific immune cell activation. Intracellular zinc homeostasis in different leukocyte subsets is regulated by distinct patterns of zinc exporter expression [52, 53]. Zinc transporter expression is important in controlling the activation and maturation of various immune cells [25, 29]. In particular, Zip 6 and ZnT 1 have been shown to be key transporters that control free zinc levels in immune cells. Intracellular zinc levels and Zip 6 are involved in the maturation of DC, and a reduction in cellular zinc or Zip 6 expression leads to enhanced antigen presentation and DC-mediated immune responses [29]. We hypothesized that alteration and/or dysregulation of zinc transporter expression with age can potentially lead to age-associated decline in zinc status, aberrant immune activation and inflammation. We confirmed the role of Zip 6 in mediating the inflammatory response, where loss of Zip 6 mRNA expression by siRNA or with age resulted in an enhanced inflammatory response (Fig. 3).

Epigenetic alterations during aging are emerging as factors that can influence age-related processes, such as chronic inflammation. In the context of the immune system, epigenetic modifications including DNA methylation and histone modifications have been shown to control immune function [35]. For example, Agrawal et al. [36] recently demonstrated that epigenetic modifications in aged human DNA increase its immunogenicity, resulting in increased DC activation, and may be a potential mechanism leading to age-associated increases in autoimmune and proinflammatory responses. In addition to age-related epigenetic modifications, specific nutrients can also modulate epigenetic regulation and alter disease susceptibility [39, 54, 55]. In particular, there is strong evidence for a role of zinc in DNA methylation [56, 57]. Zinc deficiency may cause methyl deficiency [58, 59], similar to other methyl donors like folate, resulting in altered methylation patterns, abnormal gene expression and developmental defects. Interestingly, several zinc transporters have been reported to be susceptible to epigenetic regulation [37, 38]. We hypothesized that age-related epigenetic modification of zinc transporters, particularly Zip 6, may contribute to Zip 6 dysregulation and the decline of zinc status with age. In our study, we determined changes in methylation status with age in immune cells and observed global DNA hypomethylation in the spleens of aged mice compared to young mice (Fig. 3).

At the same time, DNA methylation status of CpG islands in the promoter region of Zip 6 was increased in the splenocytes of aged mice relative to young mice. Similar promoter hypermethylations were also observed in ZnT 1 and ZnT 5 (data not shown). Thus, age-related epigenetic alterations may represent one mechanism that contributes to age-related deficits in cellular zinc levels and enhanced inflammation. Preliminary results in zinc supplemented old mice with improved zinc status did not reveal changes in Zip 6 promoter methylation compared to old mice fed a ZA diet (data not shown). However, the methylation assay used in this report may not be sensitive enough to detect subtle changes in DNA methylation profile under dietary zinc supplementation conditions. Detailed characterization of the specific CpG residues within various zinc transporter promoter regions that are differentially methylated with age and zinc status is currently ongoing using methylation assays with improved sensitivity. Secondly, it is also possible that age-related epigenetic dysregulation of Zip6 is not reversible, but zinc supplementation simply overcomes losses in cellular zinc and exerts anti-inflammatory effects, despite continued dysregulation of methylation and zinc transporter expression. Taken together, our data suggested that age-related epigenetic alterations may contribute to deficits in cellular zinc levels in immune cells and enhance inflammation. Results from our animal studies will aid in providing rationale for future human studies that will help understand whether improving zinc status in the elderly will be helpful in correcting age-related immune defects and prevent chronic inflammation.

To date, the precise factors contributing to age-related zinc deficiency remain poorly defined. Results from the current study lend support to the hypothesis that age-related epigenetic modifications such as DNA methylation may be one of the contributing factors that lead to the dysregulation of zinc regulatory proteins such as zinc transporters. This may lead to impaired zinc utilization and age-associated decline in zinc status. The resulting zinc loss, particularly in immune cells, may subsequently contribute to immune dysfunction and enhanced inflammatory response. We further showed that improving zinc status in the aged mice via dietary zinc supplementation can overcome age-related chronic inflammation. Future studies will focus on further characterizing how age-related epigenetic modifications, either with age itself or in combination with age-related zinc deficiency, could impact key regulatory mechanisms that exacerbate intracellular zinc loss, immune dysregulation and chronic inflammation. Ultimately, these studies aid in the identification of factors that may influence zinc status and contribute to the promotion of inflammation-mediated disorders with age.

Return to the ZINC Page

Since 7-21-2013

         © 1995–2018 ~ The Chiropractic Resource Organization ~ All Rights Reserved